Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer’s disease

BACKGROUND: Neuroinflammation has gained increasing attention as a potential contributing factor in Alzheimer’s disease (AD) pathology. A clinical cerebrospinal fluid biomarker capable of monitoring this process during the course of the disease has yet to emerge, chiefly owing to contradictory resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Brosseron, Frederic, Traschütz, Andreas, Widmann, Catherine N., Kummer, Markus P., Tacik, Pawel, Santarelli, Francesco, Jessen, Frank, Heneka, Michael T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828084/
https://www.ncbi.nlm.nih.gov/pubmed/29482610
http://dx.doi.org/10.1186/s13195-018-0353-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828084/
https://www.ncbi.nlm.nih.gov/pubmed/29482610
http://dx.doi.org/10.1186/s13195-018-0353-3

Ejemplares similares